Magnus is the Head of Innovation at AstraZeneca, where he leads the Digital Science, Business Development and Science & Innovation teams within Pharmaceutical Technology & Development. With a career spanning both academia and industry, Magnus brings expertise that allows him to act at the interfaces between chemistry, physics, biology, material science, spectroscopy and applied mathematics, including artificial intelligence. At AstraZeneca, Magnus is at the forefront of integrating AI and digital science to transform pharmaceutical development. He leads a program aimed at creating a holistic digital twin of AstraZeneca’s Pharmaceutical Technology & Development business, employing various AI methods, including Generative AI. This initiative seeks to transform the development process, reduce costs, lower the carbon footprint, and enhance efficiency of scientists in the organization, ultimately improving the accessibility and affordability of medicines for our patients. He holds an MSc and PhD in Physical Chemistry/Materials Science (Lund University), specialization in Nuclear Magnetic Resonance (NMR).
Forum Sessions:
Future Is Now: Operational Historians/Industrial Data Platforms, Digital Twins, AI, & What’s Next